Literature DB >> 7569976

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis.

N Auphan1, J A DiDonato, C Rosette, A Helmberg, M Karin.   

Abstract

Glucocorticoids are among the most potent anti-inflammatory and immunosuppressive agents. They inhibit synthesis of almost all known cytokines and of several cell surface molecules required for immune function, but the mechanism underlying this activity has been unclear. Here it is shown that glucocorticoids are potent inhibitors of nuclear factor kappa B (NF-kappa B) activation in mice and cultured cells. This inhibition is mediated by induction of the I kappa B alpha inhibitory protein, which traps activated NF-kappa B in inactive cytoplasmic complexes. Because NF-kappa B activates many immunoregulatory genes in response to pro-inflammatory stimuli, the inhibition of its activity can be a major component of the anti-inflammatory activity of glucocorticoids.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7569976     DOI: 10.1126/science.270.5234.286

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  462 in total

Review 1.  Regulation of inducible gene expression by the transcription factor NF-kappaB.

Authors:  S Ghosh
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  Molecular mechanisms of glucocorticoid action: what is important?

Authors:  R Newton
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

3.  Monocyte-derived dendritic cells: a potential target for therapy in multiple sclerosis (MS).

Authors:  M E Duddy; G Dickson; S A Hawkins; M A Armstrong
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

4.  Activation of nuclear factor kappaB as a target for anti-inflammatory therapy.

Authors:  S Schreiber
Journal:  Gut       Date:  1999-03       Impact factor: 23.059

5.  Functional genomics in gastroenterology.

Authors:  S Schreiber; J Hampe; H Eickhoff; H Lehrach
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

6.  Inhibition of IL-2-induced Jak-STAT signaling by glucocorticoids.

Authors:  M Bianchi; C Meng; L B Ivashkiv
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

Review 7.  Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer.

Authors:  Y Yamamoto; R B Gaynor
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

8.  Inhibition of microglial nitric oxide production by hydrocortisone and glucocorticoid precursors.

Authors:  J Y Chang; L Z Liu
Journal:  Neurochem Res       Date:  2000-07       Impact factor: 3.996

Review 9.  [Update of rheumatology--II. State and prospectives of chemotherapy in chronic arthritis].

Authors:  G Hein; T Eidner; P Oelzner; B Manger
Journal:  Med Klin (Munich)       Date:  1999-10-15

10.  Il-1 beta-induced post-transition effect of NF-kappaB provides time-dependent wave of signals for initial phase of intrapostatic inflammation.

Authors:  Eugene V Vykhovanets; Sanjeev Shukla; Gregory T MacLennan; Olena V Vykhovanets; Donald R Bodner; Sanjay Gupta
Journal:  Prostate       Date:  2009-05-01       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.